Mednax Inc (MD) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.154x

Based on the latest financial reports, Mednax Inc (MD) has a cash flow conversion efficiency ratio of 0.154x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($137.28 Million) by net assets ($890.67 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Mednax Inc - Cash Flow Conversion Efficiency Trend (1994–2024)

This chart illustrates how Mednax Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Mednax Inc (MD) financial obligations for a breakdown of total debt and financial obligations.

Mednax Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mednax Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Nantong Jiangshan Agrochemical & Chemicals Co Ltd
SHG:600389
0.047x
Sirius Real Estate Ltd
JSE:SRE
0.019x
Mesoblast Ltd
NASDAQ:MESO
-0.027x
Stoke Therapeutics Inc
NASDAQ:STOK
-0.099x
Pharvaris BV
NASDAQ:PHVS
-0.098x
TianJin 712 Communication & Broadcasting Co Ltd
SHG:603712
-0.053x
John Wiley & Sons
NYSE:WLY
-0.116x
DANAOS CORP. DL -01
F:DVW1
0.047x

Annual Cash Flow Conversion Efficiency for Mednax Inc (1994–2024)

The table below shows the annual cash flow conversion efficiency of Mednax Inc from 1994 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Mednax Inc worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $764.94 Million $206.57 Million 0.270x +66.97%
2023-12-31 $849.06 Million $137.32 Million 0.162x -13.62%
2022-12-31 $891.63 Million $166.94 Million 0.187x +118.78%
2021-12-31 $896.69 Million $76.74 Million 0.086x -68.73%
2020-12-31 $747.72 Million $204.62 Million 0.274x +18.34%
2019-12-31 $1.50 Billion $346.64 Million 0.231x +146.29%
2018-12-31 $3.09 Billion $289.93 Million 0.094x -43.70%
2017-12-31 $3.07 Billion $511.38 Million 0.167x +3.75%
2016-12-31 $2.76 Billion $443.78 Million 0.161x +6.28%
2015-12-31 $2.44 Billion $368.70 Million 0.151x -18.93%
2014-12-31 $2.27 Billion $422.64 Million 0.187x +7.82%
2013-12-31 $2.34 Billion $405.40 Million 0.173x +8.13%
2012-12-31 $2.04 Billion $325.69 Million 0.160x +2.20%
2011-12-31 $1.73 Billion $271.02 Million 0.157x -5.79%
2010-12-31 $1.45 Billion $240.56 Million 0.166x -18.06%
2009-12-31 $1.19 Billion $241.37 Million 0.203x +7.91%
2008-12-31 $965.14 Million $181.39 Million 0.188x -4.39%
2007-12-31 $959.05 Million $188.52 Million 0.197x -3.99%
2006-12-31 $865.80 Million $177.27 Million 0.205x -12.79%
2005-12-31 $691.79 Million $162.42 Million 0.235x +8.33%
2004-12-31 $571.03 Million $123.75 Million 0.217x +5.09%
2003-12-31 $572.38 Million $118.03 Million 0.206x +15.50%
2002-12-31 $548.00 Million $97.84 Million 0.179x -5.36%
2001-12-31 $478.85 Million $90.34 Million 0.189x +26.24%
2000-12-31 $241.90 Million $36.15 Million 0.149x +42.53%
1999-12-31 $228.90 Million $24.00 Million 0.105x -35.66%
1998-12-31 $207.40 Million $33.80 Million 0.163x -8.01%
1997-12-31 $163.70 Million $29.00 Million 0.177x +63.15%
1996-12-31 $136.30 Million $14.80 Million 0.109x +15.58%
1995-12-31 $62.80 Million $5.90 Million 0.094x -71.99%
1994-12-31 $16.10 Million $5.40 Million 0.335x --

About Mednax Inc

NYSE:MD USA Medical Care Facilities
Market Cap
$1.95 Billion
Market Cap Rank
#6631 Global
#1949 in USA
Share Price
$22.75
Change (1 day)
+1.07%
52-Week Range
$11.98 - $24.65
All Time High
$82.61
About

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric … Read more